BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15293994)

  • 1. Solution structure of amyloid beta-peptide (25-35) in different media.
    D'Ursi AM; Armenante MR; Guerrini R; Salvadori S; Sorrentino G; Picone D
    J Med Chem; 2004 Aug; 47(17):4231-8. PubMed ID: 15293994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
    Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
    Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?
    Watson AA; Fairlie DP; Craik DJ
    Biochemistry; 1998 Sep; 37(37):12700-6. PubMed ID: 9737846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of amyloid beta fragments in aqueous environments.
    Takano K; Endo S; Mukaiyama A; Chon H; Matsumura H; Koga Y; Kanaya S
    FEBS J; 2006 Jan; 273(1):150-8. PubMed ID: 16367755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of D-amino acids at Asp23 and Ser26 residues on the conformational preference of Abeta20-29 peptides.
    Shanmugam G; Polavarapu PL; Hallgas B; Majer Z
    Biochem Biophys Res Commun; 2005 Sep; 335(3):712-22. PubMed ID: 16091285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
    Dong X; Chen W; Mousseau N; Derreumaux P
    J Chem Phys; 2008 Mar; 128(12):125108. PubMed ID: 18376983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring interaction of beta-amyloid segment (25-35) with membrane models through paramagnetic probes.
    Esposito C; Tedeschi A; Scrima M; D'errico G; Ottaviani MF; Rovero P; D'ursi AM
    J Pept Sci; 2006 Dec; 12(12):766-74. PubMed ID: 17131288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational transition of amyloid beta-peptide.
    Xu Y; Shen J; Luo X; Zhu W; Chen K; Ma J; Jiang H
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5403-7. PubMed ID: 15800039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
    Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
    Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of amyloid beta peptide fragment (25-35) in different microenvironments.
    Shanmugam G; Jayakumar R
    Biopolymers; 2004; 76(5):421-34. PubMed ID: 15468066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides.
    Lim KH; Collver HH; Le YT; Nagchowdhuri P; Kenney JM
    Biochem Biophys Res Commun; 2007 Feb; 353(2):443-9. PubMed ID: 17184733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E, K16F).
    Poulsen SA; Watson AA; Fairlie DP; Craik DJ
    J Struct Biol; 2000 Jun; 130(2-3):142-52. PubMed ID: 10940222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation study on the disordered state of an Alzheimer's beta amyloid peptide Abeta(12 36) in water consisting of random-structural, beta-structural, and helical clusters.
    Ikebe J; Kamiya N; Ito J; Shindo H; Higo J
    Protein Sci; 2007 Aug; 16(8):1596-608. PubMed ID: 17656579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational analysis of the beta-amyloid peptide fragment, beta(12-28).
    Jayawickrama D; Zink S; Vander Velde D; Effiong RI; Larive CK
    J Biomol Struct Dyn; 1995 Oct; 13(2):229-44. PubMed ID: 8579784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions.
    Narayanan S; Reif B
    Biochemistry; 2005 Feb; 44(5):1444-52. PubMed ID: 15683229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
    Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
    J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational changes of the amyloid beta-peptide (1-40) adsorbed on solid surfaces.
    Giacomelli CE; Norde W
    Macromol Biosci; 2005 May; 5(5):401-7. PubMed ID: 15889393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.
    Chen Z; Krause G; Reif B
    J Mol Biol; 2005 Dec; 354(4):760-76. PubMed ID: 16271725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent.
    Baumketner A; Shea JE
    J Mol Biol; 2007 Feb; 366(1):275-85. PubMed ID: 17166516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.